CARR EDWARD (CIK 1273351) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-13). Recent activity: Buy DNTH (16,182 shares), Buy DNTH (17,500 shares), Buy DNTH (10,000 shares), Sell DNTH (15,852 shares), Sell DNTH (23,465 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | Buy | 16,182 | $289,334 |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | Buy | 17,500 | $386,225 |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | Buy | 10,000 | $217,700 |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | Sell | 15,852 | $1.3M |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | Sell | 23,465 | $1.9M |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | Sell | 3,865 | $319,481 |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | Sell | 200 | $16,676 |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | Sell | 300 | $25,659 |
Source: SEC Form 4 filings · as of 2026-03-13